Literature DB >> 18815812

Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.

M P Kim1, S I Park, S Kopetz, G E Gallick.   

Abstract

Src family kinases (SFKs) are signaling enzymes that have long been recognized to regulate critical cellular processes such as proliferation, survival, migration, and metastasis. Recently, considerable work has elucidated mechanisms by which SFKs regulate normal and pathologic processes in vascular biology, including endothelial cell proliferation and permeability. Further, when inappropriately activated, SFKs promote pathologic inflammatory processes and tumor metastasis, in part through their effects on the regulation of endothelial monolayer permeability. In this review, we discuss the roles of aberrantly activated SFKs in mediating endothelial permeability in the context of inflammatory states and tumor cell metastasis. We further summarize recent efforts to translate Src-specific inhibitors into therapy for systemic inflammatory conditions and numerous solid organ cancers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18815812      PMCID: PMC3907084          DOI: 10.1007/s00441-008-0682-9

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  107 in total

1.  Gbetagamma activation of Src induces caveolae-mediated endocytosis in endothelial cells.

Authors:  Ayesha N Shajahan; Chinnaswamy Tiruppathi; Alan V Smrcka; Asrar B Malik; Richard D Minshall
Journal:  J Biol Chem       Date:  2004-09-02       Impact factor: 5.157

2.  Gp60 activation mediates albumin transcytosis in endothelial cells by tyrosine kinase-dependent pathway.

Authors:  C Tiruppathi; W Song; M Bergenfeldt; P Sass; A B Malik
Journal:  J Biol Chem       Date:  1997-10-10       Impact factor: 5.157

Review 3.  Regulation of phagocyte migration and recruitment by Src-family kinases.

Authors:  A Baruzzi; E Caveggion; G Berton
Journal:  Cell Mol Life Sci       Date:  2008-07       Impact factor: 9.261

Review 4.  Integrins as dynamic regulators of vascular function.

Authors:  F W Luscinskas; J Lawler
Journal:  FASEB J       Date:  1994-09       Impact factor: 5.191

5.  Crystal structure of the Src family tyrosine kinase Hck.

Authors:  F Sicheri; I Moarefi; J Kuriyan
Journal:  Nature       Date:  1997-02-13       Impact factor: 49.962

6.  Caveolae-deficient endothelial cells show defects in the uptake and transport of albumin in vivo.

Authors:  W Schubert; P G Frank; B Razani; D S Park; C W Chow; M P Lisanti
Journal:  J Biol Chem       Date:  2001-10-31       Impact factor: 5.157

7.  Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation.

Authors:  T E Kmiecik; D Shalloway
Journal:  Cell       Date:  1987-04-10       Impact factor: 41.582

8.  Interleukin-8 as a macrophage-derived mediator of angiogenesis.

Authors:  A E Koch; P J Polverini; S L Kunkel; L A Harlow; L A DiPietro; V M Elner; S G Elner; R M Strieter
Journal:  Science       Date:  1992-12-11       Impact factor: 47.728

Review 9.  Src continues aging: current and future clinical directions.

Authors:  Scott Kopetz; Ami N Shah; Gary E Gallick
Journal:  Clin Cancer Res       Date:  2007-12-15       Impact factor: 12.531

10.  Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.

Authors:  Sara Weis; Jianhua Cui; Leo Barnes; David Cheresh
Journal:  J Cell Biol       Date:  2004-10-25       Impact factor: 10.539

View more
  38 in total

1.  The Src family tyrosine kinases src and yes have differential effects on inflammation-induced apoptosis in human pulmonary microvascular endothelial cells.

Authors:  Leif D Nelin; Hilary A White; Yi Jin; Jennifer K Trittmann; Bernadette Chen; Yusen Liu
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-02-26       Impact factor: 5.464

2.  Phase I study of dasatinib in combination with capecitabine, oxaliplatin and bevacizumab followed by an expanded cohort in previously untreated metastatic colorectal cancer.

Authors:  John H Strickler; Shannon McCall; Andrew B Nixon; John C Brady; Herbert Pang; Christel Rushing; Allen Cohn; Alexander Starodub; Christy Arrowood; Sherri Haley; Kellen L Meadows; Michael A Morse; Hope E Uronis; Gerard C Blobe; S David Hsu; S Yousuf Zafar; Herbert I Hurwitz
Journal:  Invest New Drugs       Date:  2013-11-01       Impact factor: 3.850

3.  Clinically relevant concentrations of lidocaine and ropivacaine inhibit TNFα-induced invasion of lung adenocarcinoma cells in vitro by blocking the activation of Akt and focal adhesion kinase.

Authors:  T Piegeler; M Schläpfer; R O Dull; D E Schwartz; A Borgeat; R D Minshall; B Beck-Schimmer
Journal:  Br J Anaesth       Date:  2015-11       Impact factor: 9.166

4.  Caveolae-Mediated Transport at the Injured Blood-Brain Barrier as an Underexplored Pathway for Central Nervous System Drug Delivery.

Authors:  Alexander G Sorets; Jonah C Rosch; Craig L Duvall; Ethan S Lippmann
Journal:  Curr Opin Chem Eng       Date:  2020-09-12       Impact factor: 5.163

Review 5.  Steps in prostate cancer progression that lead to bone metastasis.

Authors:  Jung-Kang Jin; Farshid Dayyani; Gary E Gallick
Journal:  Int J Cancer       Date:  2011-03-28       Impact factor: 7.396

Review 6.  Src signaling pathways in prostate cancer.

Authors:  Andreas Varkaris; Anastasia D Katsiampoura; John C Araujo; Gary E Gallick; Paul G Corn
Journal:  Cancer Metastasis Rev       Date:  2014-09       Impact factor: 9.264

7.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

8.  Antimetastatic potential of amide-linked local anesthetics: inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade.

Authors:  Tobias Piegeler; E Gina Votta-Velis; Guoquan Liu; Aaron T Place; David E Schwartz; Beatrice Beck-Schimmer; Richard D Minshall; Alain Borgeat
Journal:  Anesthesiology       Date:  2012-09       Impact factor: 7.892

9.  Crosstalk between protease-activated receptor 1 and platelet-activating factor receptor regulates melanoma cell adhesion molecule (MCAM/MUC18) expression and melanoma metastasis.

Authors:  Vladislava O Melnikova; Krishnakumar Balasubramanian; Gabriel J Villares; Andrey S Dobroff; Maya Zigler; Hua Wang; Frederik Petersson; Janet E Price; Alan Schroit; Victor G Prieto; Mien-Chie Hung; Menashe Bar-Eli
Journal:  J Biol Chem       Date:  2009-08-24       Impact factor: 5.157

10.  Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer.

Authors:  Christine M Parseghian; Nila U Parikh; Ji Yuan Wu; Zhi-Qin Jiang; Laura Henderson; Feng Tian; Brice Pastor; Marc Ychou; Kanwal Raghav; Arvind Dasari; David R Fogelman; Anastasia D Katsiampoura; David G Menter; Robert A Wolff; Cathy Eng; Michael J Overman; Alain R Thierry; Gary E Gallick; Scott Kopetz
Journal:  Clin Cancer Res       Date:  2017-03-09       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.